White to Off-White SoliChloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
Hygroscopic and Moisture SensitiveBortezomib is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found
Bortezomib is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma. This includes multiple myeloma in those who have and have not previously received treatment. It is generally used together with other medications. It is given by injection.
Member Since 5 Years
Nature of Business Trader
For Buyer 
For Seller 
Help 
Udyog Vihar Phase V, Gurugram, Haryana 
Send Enquiry